Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis
Open Access
- 6 January 2003
- journal article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 5 (2) , R82-90
Abstract
Advanced glycation end-product (AGE)-damaged IgG occurs as a result of hyperglycemia and/or oxidative stress. Autoantibodies to IgG-AGE were previously demonstrated in patients with severe, longstanding rheumatoid arthritis (RA). We investigated whether IgG-AGE and anti-IgG-AGE antibodies were present early in the course of RA and other inflammatory arthropathies. We prospectively followed a cohort of 238 patients with inflammatory arthritis of duration less than 1 year. Patients were evaluated clinically and serologically, and radiographs were obtained at initial and 1-year visits. Sera were assayed for IgG-AGE and anti-IgG-AGE antibodies by enzyme-linked immunosorbent assay (ELISA). Rheumatoid factor (RF) was determined by nephelometry and ELISA. Of all patients, 29% had RF-positive RA, 15% had RF-negative RA, 18% had spondyloarthropathy, and 38% had undifferentiated arthritis. IgG-AGE was present in 19% of patients, and was similar in amount and frequency in all groups. Patients with elevated IgG-AGE levels had significantly higher levels of the inflammatory markers C-reactive protein and erythrocyte sedimentation rate, but there was no correlation with blood glucose levels. Overall, 27% of the patients had IgM anti-IgG-AGE antibodies. These antibodies were highly significantly associated with RFs (P < 0.0001) and with swollen joint count (P < 0.01). In early onset arthritis, IgG damaged by AGE was detected in all patient groups. The ability to make IgM anti-IgG-AGE antibodies, however, was restricted to a subset of RF-positive RA patients with more active disease. The persistence of the anti-IgG-AGE response was more specific to RA, and was transient in the patients with spondyloarthropathy and with undifferentiated arthritis who were initially found to be positive for anti-IgG-AGE antibodies.Keywords
This publication has 24 references indexed in Scilit:
- Requirement for p38 and p44/p42 Mitogen-Activated Protein Kinases in RAGE-Mediated Nuclear Factor-κB Transcriptional Activation and Cytokine SecretionDiabetes, 2001
- Pathogenesis of β2‐Microglobulin Amyloidosis: Role of Monocytes/MacrophagesSeminars in Dialysis, 2001
- Advanced glycation end-products: a reviewDiabetologia, 2001
- Protein Glycation, Diabetes, and AgingRecent Progress in Hormone Research, 2001
- RAGE: A Multiligand Receptor Contributing to the Cellular Response in Diabetic Vasculopathy and InflammationSeminars in Thrombosis and Hemostasis, 2000
- Matrix-assisted laser desorption/ionization mass spectrometry, enzymatic digestion, and molecular modeling in the study of nonenzymatic glycation of IgGJournal of the American Society for Mass Spectrometry, 2000
- Lysyl oxidase and Maillard reaction‐mediated crosslinks in aging and osteoarthritic rabbit cartilageJournal of Orthopaedic Research, 1995
- Hemoglobin-AGE: A Circulating Marker of Advanced GlycosylationScience, 1992
- The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of SpondylarthropathyArthritis & Rheumatism, 1991
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988